selected publications
-
Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis.
PEC innovation.
2023
Academic Article
GET IT
Times cited: 1 - What happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testing. Cancer. 2022 Academic Article GET IT
-
Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome?.
Familial cancer.
2022
Academic Article
GET IT
Times cited: 1 -
Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2022
Review
GET IT
Times cited: 8 -
Adapting and avoiding coping strategies for women with ovarian cancer during the COVID-19 pandemic.
Gynecologic oncology.
2020
Academic Article
GET IT
Times cited: 17